Document:

EX-4.4

 Exhibit 4.4 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY
MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE 

COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT. 

 

			
	Date of Issuance	  	Void after
	July 16, 2013	  	July 16, 2023

 ANAPLAN, INC. 

WARRANT TO PURCHASE SHARES OF COMMON STOCK 

For good and valuable consideration, the receipt of which is hereby acknowledged, this Warrant is issued to Croton Partners, LLC or its
assigns (the “Holder”) by Anaplan, Inc., a Delaware corporation (the “Company”). 
 1. Purchase of Shares.

 (a) Number of Shares. Subject to the terms and conditions set forth herein, the Holder is entitled, upon surrender of this
Warrant at the principal office of the Company (or at such other place as the Company shall notify the Holder in writing), to purchase from the Company up to 50,000 fully paid and nonassessable shares of the Company’s Common Stock (the
“Common Stock”). 
 (b) Exercise Price. The exercise price for the shares of Common Stock issuable pursuant to this
Section 1 (the “Shares”) shall be $0.88 per share (the “Exercise Price”). The Shares and the Exercise Price shall be subject to adjustment pursuant to Section 9 hereof. 

2. Exercise Period. This Warrant shall be exercisable, in whole or in part, during the term commencing on July 16, 2013 and ending
at 5:00 p.m. Pacific standard time on July 16, 2023 (the “Exercise Period”); provided, however, that this Warrant shall no longer be exercisable and become null and void upon the consummation of any “Termination
Event” defined as (i) the closing of the sale, transfer or other disposition of all or substantially all of the Company’s assets, (ii) the consummation of the merger or consolidation of the Company with or into another entity
(except a merger or consolidation in which the holders of capital stock of the Company immediately prior to such merger or consolidation continue to hold at least 50% of the voting power of the capital stock of the Company or the surviving or
acquiring entity), (iii) the closing of the transfer (whether by merger, consolidation or otherwise), in one transaction or a series of related transactions, to a person or group of affiliated persons (other than an underwriter of this
corporation’s securities), of the Company’s securities if, after such closing, such person or group of affiliated persons would hold 50% or more of the outstanding voting stock of this corporation (or the surviving or acquiring entity)
(collectively, a “Corporate Transaction”). In the event of a Termination Event, the Company shall notify the Holder at least ten (10) days prior to the consummation of such Termination Event. 

SIGNATURE PAGE TO ANAPLAN, INC. COMMON
STOCK WARRANT 

 3. Method of Exercise. 

(a) While this Warrant remains outstanding and exercisable in accordance with Section 2 above, the Holder may exercise, in whole or in
part, the purchase rights evidenced hereby. Such exercise shall be effected by: 
 (i) the surrender of the Warrant, together with a duly
executed copy of the Notice of Exercise attached hereto, to the Secretary of the Company at its principal office (or at such other place as the Company shall notify the Holder in writing); and 

(ii) the payment to the Company of an amount equal to the aggregate Exercise Price for the number of Shares being purchased. 

(b) Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the day on which this
Warrant is surrendered to the Company as provided in Section 3(a) above. At such time, the person or persons in whose name or names any certificate for the Shares shall be issuable upon such exercise as provided in Section 3(c) below shall
be deemed to have become the holder or holders of record of the Shares represented by such certificate. 
 (c) As soon as practicable after
the exercise of this Warrant in whole or in part, and in any event within twenty (20) days thereafter, the Company at its expense will cause to be issued in the name of, and delivered to, the Holder, or as such Holder (upon payment by such
Holder of any applicable transfer taxes) may direct: 
 (i) a certificate or certificates for the number of Shares to which such Holder
shall be entitled, and 
 (ii) in case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor,
calling in the aggregate on the face or faces thereof for the number of Shares equal to the number of such Shares described in this Warrant minus the number of such Shares purchased by the Holder upon all exercises made in accordance with
Section 3(a) above or Section 4 below. 
 (d) Notwithstanding the provisions of Section 2, if the holder has not exercised
this Warrant prior to the closing of a Corporate Transaction, this Warrant shall automatically be deemed to be exercised in full in the manner set forth in Section 4, without any further action on behalf of the Holder immediately prior to such
closing. 
 4. Net Exercise. In lieu of exercising this Warrant for cash, the Holder may elect to receive shares equal to the value
of this Warrant (or the portion thereof being exercised) by surrender of this Warrant at the principal office of the Company together with notice of such election (a “Net Exercise”). A Holder who Net Exercises shall have the rights
described in Sections 3(b) and 3(c) hereof, and the Company shall issue to such Holder a number of Shares computed using the following formula: 

 

 
 Where 
  

			
		
	X =	  	The number of Shares to be issued to the Holder.
		
	Y =	  	The number of Shares purchasable under this Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being cancelled (at the date of such calculation).
		
	A =	  	The fair market value of one (1) Share (at the date of such calculation).
		
	B =	  	The Exercise Price (as adjusted to the date of such calculation).

 For purposes of this Section 4, the fair market value of a Share shall mean the average of the closing
prices of the Shares (or equivalent shares of Common Stock underlying this Warrant) quoted in the over-the-counter market in which the Shares (or equivalent shares of
Common Stock underlying the Warrant) are traded or the closing price quoted on any exchange or electronic securities market on which the Shares (or equivalent shares of Common Stock underlying the Warrant) are listed, whichever is applicable, as
published in The Wall Street Journal for the thirty (30) trading days prior to the date of determination of fair market value (or such shorter period of time during which such Shares were traded over-the-counter or on such exchange). If the Shares are not traded on the over-the-counter market, an exchange or an electronic
securities market, the fair market value shall be the price per Share that the Company could obtain from a willing buyer for Shares sold by the Company from authorized but unissued Shares, as such prices shall be determined in good faith by the
Company’s Board of Directors. 
 5. Representations and Warranties of the Company. In connection with the transactions provided
for herein, the Company hereby represents and warrants to the Holder that: 
 (a) Organization, Good Standing, and Qualification. The
Company is a corporation duly organized, validly existing, and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted. The Company is duly qualified to
transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties. 

(b) Authorization. Except as may be limited by applicable bankruptcy, insolvency, reorganization or similar laws relating to or
affecting the enforcement of creditors’ rights, all corporate action has been taken on the part of the Company, its officers, directors, and stockholders necessary for the authorization, execution and delivery of this Warrant. The Company has
taken all corporate action required to make all the obligations of the Company reflected in the provisions of this Warrant the valid and enforceable obligations they purport to be. The issuance of this Warrant will not be subject to preemptive
rights of any stockholders of the Company. The Company has authorized sufficient shares of Common Stock to allow for the exercise of this Warrant. 

 6. Representations and Warranties of the Holder. In connection with the transactions
provided for herein, the Holder hereby represents and warrants to the Company that: 
 (a) Authorization. Holder represents that it
has full power and authority to enter into this Warrant. This Warrant constitutes the Holder’s valid and legally binding obligation, enforceable in accordance with its terms, except as may be limited by (i) applicable bankruptcy,
insolvency, reorganization, or similar laws relating to or affecting the enforcement of creditors’ rights and (ii) laws relating to the availability of specific performance, injunctive relief or other equitable remedies. 

(b) Purchase Entirely for Own Account. The Holder acknowledges that this Warrant is entered into by the Holder in reliance upon such
Holder’s representation to the Company that the Warrant and the Shares issued upon exercise of the Warrant (collectively, the “Securities”) will be acquired for investment for the Holder’s own account, not as a nominee or agent,
and not with a view to the resale or distribution of any part thereof, and that the Holder has no present intention of selling, granting any participation in or otherwise distributing the same. By acknowledging this Warrant, the Holder further
represents that the Holder does not have any contract, undertaking, agreement, or arrangement with any person to sell, transfer or grant participations to such person or to any third person, with respect to the Securities. 

(c) Disclosure of Information. The Holder acknowledges that it has received all the information it considers necessary or appropriate
for deciding whether to acquire the Securities. The Holder further represents that it has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of the Securities. 

(d) Investment Experience. The Holder is an investor in securities of companies in the development stage and acknowledges that it is
able to fend for itself, can bear the economic risk of its investment, and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the Securities. If other than an
individual, the Holder also represents it has not been organized solely for the purpose of acquiring the Securities. 
 (e) Accredited
Investor. The Holder is an “accredited investor” within the meaning of Rule 501 of Regulation D, as presently in effect, as promulgated by the Securities and Exchange Commission (the “SEC”) under the Act. 

(f) Restricted Securities. The Holder understands that the Securities are characterized as “restricted securities” under the
federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the Act, only
in certain limited circumstances. In this connection, each Holder represents that it is familiar with Rule 144, as presently in effect, as promulgated by the SEC under the Act (“Rule 144”), and understands the resale limitations imposed
thereby and by the Act. 

 (g) Further Limitations on Disposition. Without in any way limiting the representations
set forth above, the Holder further agrees not to make any disposition of all or any portion of the Shares unless and until the transferee has agreed in writing for the benefit of the Company to be bound by the terms of this Warrant, including,
without limitation, this Section 6, Section 20, and: 
 (i) there is then in effect a registration statement under the Act
covering such proposed disposition and such disposition is made in accordance with such registration statement; or 
 (ii) the Holder shall
have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder shall have
furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of such shares under the Act. It is agreed that the Company will not require opinions of counsel for
transactions made pursuant to Rule 144 except in extraordinary circumstances. 
 (h) Legends. It is understood that the Securities
may bear the following legend: 
 “THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT
BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS
NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.” 
 7. State Commissioners of Corporations. THE
SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS WARRANT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION FOR
SUCH SECURITIES PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS WARRANT ARE EXPRESSLY
CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT. 
 8. Adjustment of Exercise Price and Number of
Shares. The number and kind of Shares purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows: 

(a) Subdivisions, Combinations and Other Issuances. If the Company shall at any time after the issuance but prior to the expiration of
this Warrant subdivide its Common Stock, by split-up or otherwise, or combine its Common Stock, or issue additional shares of its Preferred Stock or Common Stock as a dividend with respect to any shares of its
Common Stock, the number of Shares issuable on the exercise of this Warrant shall forthwith be proportionately 

 
increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments shall also be made to the Exercise Price payable per
share, but the aggregate Exercise Price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 8(a) shall become effective at the close of business on the
date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the making of such dividend. 

(b) Reclassification, Reorganization and Consolidation. In case of any reclassification, capital reorganization or change in the
capital stock of the Company (other than as a result of a subdivision, combination or stock dividend provided for in Section 8(a) above), then, as a condition of such reclassification, reorganization or change, lawful provision shall be made,
and duly executed documents evidencing the same from the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right at any time prior to the expiration of this Warrant to purchase, at a total price equal to
that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities or property receivable in connection with such reclassification, reorganization or change by a holder of the same number and type of
securities as were purchasable as Shares by the Holder immediately prior to such reclassification, reorganization or change. In any such case appropriate provisions shall be made with respect to the rights and interest of the Holder so that the
provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities or property deliverable upon exercise hereof, and appropriate adjustments shall be made to the Exercise Price per Share payable hereunder,
provided the aggregate Exercise Price shall remain the same. 
 (c) Notice of Adjustment. When any adjustment is required to
be made in the number or kind of shares purchasable upon exercise of the Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of Shares or other securities or property thereafter purchasable
upon exercise of this Warrant. 
 9. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect. 

10. No Stockholder Rights. Prior to exercise of this Warrant, the Holder shall not be entitled to any rights of a stockholder with
respect to the Shares, including (without limitation) the right to vote such Shares, receive dividends or other distributions thereon, exercise preemptive rights or be notified of stockholder meetings, and, except as otherwise provided in this
Warrant, such Holder shall not be entitled to any stockholder notice or other communication concerning the business or affairs of the Company. 

11. Right of First Refusal of Company. 

(a) Right of First Refusal. In the event that the Holder proposes to sell, pledge or otherwise transfer to a third party any Shares, or
any interest in Shares, the Company shall have a right of first refusal (the “Right of First Refusal”) with respect to all or any portion of such Shares. If the Holder desires to transfer Shares, Holder shall give a written transfer

 
notice (“Transfer Notice”) to the Company describing fully the proposed transfer, including the number of Shares proposed to be transferred, the proposed transfer price, the name
and address of the proposed person to whom the Holder would directly or indirectly transfer such Shares (the “Transferee”) and proof satisfactory to the Company that the proposed sale or transfer will not violate any applicable
federal, State or foreign securities laws. The Transfer Notice shall be signed both by the Holder and by the proposed Transferee and must constitute a binding commitment of both parties to the transfer of the Shares. The Company shall have the right
to purchase all or any portion of the Shares on the terms of the proposal described in the Transfer Notice (subject, however, to any change in such terms permitted under Subsection (b) below) by delivery of a notice of exercise of the Right of
First Refusal within 30 days after the date when the Transfer Notice was received by the Company. 
 (b) Transfer of Shares. If the
Company fails to exercise its Right of First Refusal within 30 days after receiving the Transfer Notice, the Holder may, not later than 90 days after the Company received the Transfer Notice, conclude a transfer of the Shares subject to
the Transfer Notice on the terms and conditions described in the Transfer Notice, provided that any such sale is made in compliance with applicable federal, State and foreign securities laws and not in violation of any other contractual restrictions
to which the Holder is bound. Any proposed transfer on terms and conditions different from those described in the Transfer Notice, as well as any subsequent proposed transfer by the Holder, shall again be subject to the Right of First Refusal and
shall require compliance with the procedure described in Subsection (a) above. If the Company exercises its Right of First Refusal, the parties shall consummate the sale of the Shares on the terms set forth in the Transfer Notice within
60 days after the Company received the Transfer Notice (or within such longer period as may have been specified in the Transfer Notice); provided, however, that in the event the Transfer Notice provided that payment for the Shares was to be
made in a form other than cash or cash equivalents paid at the time of transfer, the Company shall have the option of paying for the Shares with cash or cash equivalents equal to the present value of the consideration described in the Transfer
Notice. 
 (c) Additional or Exchanged Securities and Property. In the event of a merger or consolidation of the Company with or into
another entity, any other corporate reorganization, a stock split, the declaration of a stock dividend, the declaration of an extraordinary dividend payable in a form other than stock, a spin-off, an
adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities, any securities or other property (including cash or cash equivalents) that are by reason of such transaction exchanged
for, or distributed with respect to, any Shares subject to this Section 11 shall immediately be subject to the Right of First Refusal. Appropriate adjustments to reflect the exchange or distribution of such securities or property shall be made
to the number and/or class of the Shares subject to this Section 11. 
 (d) Termination of Right of First Refusal. Any other
provision of this Section 11 notwithstanding, in the event that the Stock is readily tradable on an established public securities market when the Holder desires to transfer Shares, the Company shall have no Right of First Refusal, and Holder
shall have no obligation to comply with the procedures prescribed by Subsections (a) and (b) above. 

 (e) Assignment of Right of First Refusal. The Company may freely assign the Company’s
Right of First Refusal, in whole or in part. Any person who accepts an assignment of the Right of First Refusal from the Company shall assume all of the Company’s rights and obligations under this Section 11. 

12. Governing Law. This Warrant shall be governed by and construed under the laws of the State of California as applied to agreements
among California residents, made and to be performed entirely within the State of California. 
 13. Successors and Assigns. The
terms and provisions of this Warrant and the Purchase Agreement shall inure to the benefit of, and be binding upon, the Company and the holders hereof and their respective successors and assigns. 

14. Titles and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in
construing or interpreting this Warrant. 
 15. Notices. All notices and other communications given or made pursuant hereto shall be
in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient, and if not so
confirmed, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier,
specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective parties at the following addresses (or at such other addresses as shall be specified by notice given in accordance with this
Section 15): 
 If to the Company: 

ANAPLAN, INC. 
 240
Stockton St., Fifth Floor 
 San Francisco, CA 94108 

Attention: President 
 If to
Holder: 
 At the addresses shown on the signature pages hereto. 

16. Finder’s Fee. Each party represents that it neither is or will be obligated for any finder’s fee or commission in
connection with this transaction. The Holder agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder’s fee (and the costs and expenses of defending against such
liability or asserted liability) for which the Holder or any of its officers, partners, employees or representatives is responsible. The Company agrees to indemnify and hold harmless the Holder from any liability for any commission or compensation
in the nature of a finder’s fee (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible. 

 17. Expenses. If any action at law or in equity is necessary to enforce or interpret the
terms of this Warrant, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 

18. Entire Agreement; Amendments and Waivers. This Warrant and any other documents delivered pursuant hereto constitute the full and
entire understanding and agreement between the parties with regard to the subjects hereof and thereof. Nonetheless, any term of this Warrant may be amended and the observance of any term of this Agreement may be waived (either generally or in a
particular instance and either retroactively or prospectively), with the written consent of the Company and the Holder; or if this Warrant has been assigned in part, by the holders or rights to purchase a majority of the shares originally issuable
pursuant to this Warrant. 
 19. Severability. If any provision of this Warrant is held to be unenforceable under applicable law,
such provision shall be excluded from this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 

20. “Market Stand-Off” Agreement. The Holder hereby agrees that it will not, without
the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the consummation of the Company’s sale of its Common Stock or other securities pursuant to a registration
statement under the Securities Act of 1933, as amended (other than a registration statement relating either to sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a SEC Rule 145 transaction)
(an “Initial Public Offering”) and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days) (i) lend, offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of the Company’s capital stock acquired through the exercise
of this Warrant, or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Company’s capital stock acquired through the exercise of this Warrant,
whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of securities, in cash or otherwise. The underwriters in connection with the Company’s Initial Public Offering are intended third party
beneficiaries of this Section and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in
the Company’s Initial Public Offering that are consistent with this Section 20 or that are necessary to give further effect thereto. 

In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with
respect to the Securities of each Holder (and the shares or securities of every other person subject to the foregoing restriction) until the end of such period. Notwithstanding the foregoing, if (i) during the last seventeen (17) days of
the one hundred eighty (180)-day restricted period, the Company issues an earnings release or material news or a material event relating to the Company occurs; or (ii) prior to the expiration of the one
hundred eighty (180)-day restricted period, the Company announces that it will release earnings results during the 

 
sixteen (16)-day period beginning on the last day of the one hundred eighty (180)-day period, the restrictions
imposed by this Section 20 shall continue to apply until the expiration of the eighteen (18)-day period beginning on the issuance of the earnings release or the occurrence of the material news or material
event. 
 Each Holder agrees that a legend reading substantially as follows shall be placed on all certificates representing all capital
stock of each Holder (and the shares or securities of every other person subject to the restriction contained in this Section 20): 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD AFTER THE EFFECTIVE DATE
OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE ACT, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES. 

 IN WITNESS WHEREOF, the parties have executed this Warrant as of the date first written above.

  

					
		 	ANAPLAN, INC.
			
		 	By:	 	/s/ Fred Laluyaux
		 		 	Fred Laluyaux, President and CEO
		 		 	
	Address:    	 	240 Stockton St., Fifth Floor
		 	San Francisco, CA 94108

  

			
	ACKNOWLEDGED AND AGREED:
	
	HOLDER
	
	CROTON PARTNERS, LLC
		
	By:	 	/s/ James Chung

			
	Name:	 	James Chung
	Title:	 	Managing Director

			
		
	 Address:
	 	 2755 Campus Dr., Suite 220
 San Mateo, CA
94403

 SIGNATURE PAGE TO ANAPLAN, INC.
COMMON STOCK WARRANT 

 NOTICE OF EXERCISE 

ANAPLAN, INC, 
 Attention: Corporate Secretary 

The undersigned hereby elects to purchase, pursuant to the provisions of the Warrant, as follows: 

 

	 	❑	                             shares of Common Stock pursuant to the
terms of the attached Warrant, and tenders herewith payment in cash of the Exercise Price of such Shares in full, together with all applicable transfer taxes, if any. 

 

	 	❑	Net Exercise the attached Warrant with respect to                      Shares. 

The undersigned hereby represents and warrants that Representations and Warranties in Section 6 hereof are true and correct as of the
date hereof. 
  

							
		 		 	 HOLDER:

							
				
	Date:                                     
   	 		 	By:	 	 
			
		 	Address:	 	 
		 		 	 
		 		 	 
			
	Name in which shares should be registered:EX-10.1

 Exhibit 10.1 

FIRST AMENDMENT TO CREDIT AGREEMENT 

AND LOAN PARTIES’ CONSENT 

THIS FIRST AMENDMENT TO CREDIT AGREEMENT AND LOAN PARTIES’ CONSENT (the “First Amendment”) is entered into effective the 7th day of September 2018, by and among PAYCOM PAYROLL, LLC (the “Borrower”), PAYCOM SOFTWARE, INC., WCAS PAYCOM HOLDINGS, INC., WCAS CP IV BLOCKER, INC., PAYCOM BENEFITS, LLC, and PAYCOM
PAYROLL HOLDINGS, LLC (collectively, the “Loan Parties”), JPMORGAN CHASE BANK, N.A., as Administrative Agent, Sole Bookrunner, Sole Lead Arranger and Lender (the “Administrative Agent”), BANK OF AMERICA, N.A. and KIRKPATRICK BANK
(each, a “Lender” and collectively with the Administrative Agent, the “Lenders”). 
 W I T N E S S E T H: 

WHEREAS, the Borrower and the Lenders have entered into a certain Term Credit Agreement dated effective December 7, 2017 (the
“Credit Agreement”); and 
 WHEREAS, the Borrower, the Loan Parties and the Lenders desire to amend the terms of the Credit
Agreement by the terms of this First Amendment; 
 NOW THEREFORE, in consideration of the recitals, Ten Dollars ($10.00), and other good and
valuable consideration, the receipt of which is hereby acknowledged, it is agreed as follows: 
 1.    Defined Terms. Except as
otherwise defined herein, all terms defined in the Credit Agreement will have the same meaning herein. 
 2.    Amendments. The
Credit Agreement is hereby amended as follows: 
  

	 	2.1.	 The “Term Loan Draw Expiration Date” is hereby extended to March 7, 2019. Accordingly, the
definition of the term “Term Loan Draw Expiration Date” in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirely as follows: 

“ “Term Loan Draw Expiration Date” means March 7, 2019.” 

 

	 	2.2.	 Section 2.10(a) of the Credit Agreement is hereby amended and restated in its entirety as follows:

  

	 	“2.10	 Repayment and Amortization of Loans; Evidence of Debt. 

 

	 	(a)	 The Borrower hereby unconditionally promises to pay to the Administrative Agent for the account of the Lenders
in accordance with their respective Applicable Percentages (i) principal installments on the last day of each fiscal quarter, beginning on September 30, 

	 	
2018, with each scheduled installment being an amount equal to 0.0125 multiplied by the aggregate principal amount of all Term Loans outstanding on September 30, 2018; (ii) principal
installments on the last day of each fiscal quarter, beginning on March 31, 2019 with each such scheduled installment being an amount equal to 0.0125 multiplied by the aggregate principal amount advanced to the Borrower under the Term
Loans at any time after September 30, 2018 but on or before the Term Loan Draw Expiration Date; and (iii) the unpaid principal amount of all Term loans on the Term Loan Maturity Date (which the Borrower acknowledges will be a balloon
payment).” 

 3.    Release. Except for Lenders’ obligations under the Credit Agreement as amended by
this First Amendment and the Loan Documents, the Borrower and the Loan Parties hereby, jointly and severally, release, acquit and forever discharge the Lenders and the Lenders’ subsidiaries, affiliates, officers, directors, shareholders,
agents, employees, attorneys and representatives, as well as the respective heirs, personal representatives, successors and assigns of any and all of them (hereafter collectively referred to as the “Released Lender Parties”) from any and
all claims, demands, debts, actions, causes of action, suits, contracts, agreements, obligations, accounts, defenses, offsets against indebtedness and liabilities of any kind or character whatsoever, known or unknown, suspected or unsuspected, in
contract or in tort, at law or in equity, including without implied limitation, such claims and defenses as fraud, mistake, duress and usury, which the Borrower or any of the Loan Parties ever had, now have or might hereafter have against the
Released Lender Parties, jointly or severally, for or by reason of any matter, cause or thing whatsoever occurring on or before the date of this First Amendment, whether or not related in whole or in part, directly or indirectly to any of the Loan
Documents. In addition, the Borrower and the Loan Parties hereby, jointly and severally, agree not to commence, join in, prosecute or participate in any suit or other proceeding in a position which is adverse to any of the Released Lender Parties
arising directly or indirectly from any of the foregoing matters. 
 4.    No Defenses. Borrower and Loan Parties jointly and
severally acknowledge and agree that Borrower and Loan Parties do not have any defense, offset, counterclaim or right of recoupment with respect to (i) payment or performance of Borrower’s Obligations owing to the Lenders; or (ii) any
of the Loan Parties’ unconditional obligations to pay the Obligations under the terms of their Loan Guaranty. Borrower and Loan Parties acknowledge and agree that this First Amendment shall not establish a course of dealing or be construed as
evidence of any willingness or commitment on the part of Lenders to agree to other or future amendments to the Credit Agreement, as amended by this First Amendment, or to any renewals or modifications of any of the Loan Documents. 

5.    Loan Parties’ Consent; Ratification. The Loan Parties hereby jointly and severally consent to the modifications made to
the Credit Agreement by the terms of this First Amendment. The Loan Parties hereby jointly and severally ratify, confirm, and agree to be bound by all of the terms and conditions contained in the Credit Agreement, as amended by the terms of this
First Amendment. The Loan Parties hereby ratify, confirm and agree to be bound by all of their obligations under their Loan Guaranty, the terms of which will all remain in full force and effect, and the Loan Parties agree that their obligations
thereunder will not be reduced by virtue of any capital contributions previously made or to be made in the future to the Borrower. 

 6.    Conditions to First Amendment. The Lenders will have no obligation to
accept or execute this First Amendment until all of the following conditions precedent have been completely satisfied as determined by Administrative Agent in Administrative Agent’s sole discretion: 

 

	 	6.1	 The Borrower and all of the Loan Parties shall have executed and delivered to Lenders a counterpart of this
First Amendment. 

  

	 	6.2	 The Lenders shall have approved the terms of this First Amendment. 

7.    Counterparts. This First Amendment may be executed in two (2) or more counterparts, each of which will constitute an
original instrument, but all of which taken together will be one agreement. 
 8.    Entire Agreement. This First Amendment
supersedes and replaces all prior oral and written negotiations and agreements related to the subject matter hereof. 
 9.    Full
Force and Effect. Except to the extent amended by this First Amendment, the Credit Agreement and all of the Loan Documents, and the liens created thereby, will all remain in full force and effect, unabated and uninterrupted, and are all hereby
ratified and approved. 
 [Signature pages follow.] 

 IN WITNESS WHEREOF, the parties have caused this instrument to be duly executed as of the
day and year first above written. 
  

			
	PAYCOM PAYROLL, LLC
		
	By:	 	/s/ Craig Boelte
		 	Craig Boelte, Chief Financial Officer
	
	(the “Borrower”)
	
	PAYCOM SOFTWARE, INC.
		
	By:	 	/s/ Craig Boelte
		 	Craig Boelte, Chief Financial Officer
	
	WCAS PAYCOM HOLDINGS, INC.
		
	By:	 	/s/ Craig Boelte
		 	Craig Boelte, Chief Financial Officer
	
	WCAS CP IV BLOCKER, INC.
		
	By:	 	/s/ Craig Boelte
		 	Craig Boelte, Chief Financial Officer
	
	PAYCOM BENEFITS, LLC
		
	By:	 	/s/ Craig Boelte
		 	Craig Boelte, Chief Financial Officer
	
	PAYCOM PAYROLL HOLDINGS, LLC
		
	By:	 	/s/ Craig Boelte
		 	Craig Boelte, Chief Financial Officer
	
	(the “Loan Parties”)
	
	JPMORGAN CHASE BANK, N.A., individually, and as Administrative Agent
		
	By:	 	/s/ David Jackson
		 	David Jackson, Executive Director
	
	 (“Administrative Agent” and “Lender”)

 
			
	BANK OF AMERICA, N.A.
		
	By:	 	/s/ Lisa M Chrzanowski
	Name:	 	Lisa M Chrzanowski
	Title:	 	SVP
	
	KIRKPATRICK BANK
		
	By:	 	/s/ George Drew
	Name:	 	George Drew
	Title:	 	President & CEO
	
	(the “Lenders”)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}]]